Inflammation and Fibrosis Markers Predict Adverse Outcomes in Arrhythmogenic Cardiomyopathy: An Integrated Multiomics Study

30 March 2025 (09:12 - 09:21)
Organised by: Logo
Congress Presentation Part of: Basic science and arrhythmia pathophysiology Pathophysiology and Mechanisms EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by